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People with Parkinson’s disease (PD) may be at increased risk of delirium and associated 
adverse outcomes. Delirium is an acute neuropsychiatric syndrome defined by confusion 
and inattention and is common in older adults. Previous studies may have underestimated 
the prevalence of delirium in PD due to overlapping symptoms, lack of awareness and 
poorly defined criteria. We aimed to identify the prevalence and incidence of delirium in 
inpatients with PD. 
Measurements 
Participants were inpatients with PD admitted over a four-month period. Delirium  
prevalence was classified using a standardised assessment at a single visit based on the 
Diagnostic and Statistical Manual of Mental Disorders 5th Edition (DSM-5) criteria. To 
capture remaining time in hospital, incident delirium was diagnosed using detailed clinical 
vignettes and a validated consensus method. 
Results 
Forty-four PD patients consented to take part in the study, accounting for 53 admissions. 
Delirium  prevalence was 34.0% (n=18); reviewing participants over the duration of their 










hospital stay identified 30 (56.6%) incident delirium cases. The admitting team screened 
24.5% for delirium and delirium was documented in eight (14.8%) cases’ medical notes. 
Cases with delirium were significantly older, had higher frailty scores and a longer hospital 
stay (p<0.05 for all). 
Conclusions 
Delirium is common in PD inpatients at admission and incidence increases during hospital 
stay, but delirium commonly missed. Our results highlight the importance of screening for 
delirium throughout patients’ stay in hospital. Future studies should consider frequent 
evaluation over the duration of hospital stay to identify emergent delirium during the 
admission.  
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Key points:  
 Prevalent delirium occurred in over a third of inpatient Parkinson’s admissions. 
 Incident delirium increased to more than half of Parkinson’s admission. 
 Delirium reporting was low both in the medical notes and in discharge letters. 
 Delirium cases were older, frailer and had a longer hospital stay. 
  











Delirium is a serious acute neuropsychiatric syndrome that is common in older adults 
admitted to hospital and is characterised by altered levels of consciousness, confusion and 
impaired attention.1 In older adults, delirium has been associated with poorer outcomes, 
such as dementia,2 mortality and institutionalisation.3 A recent systematic review suggested 
that people with Parkinson’s disease (PD) may be at increased risk of delirium.4 Parkinson’s 
disease is a movement disorder5 predominantly affecting older adults and is associated with 
frequent non-motor features.  
The reported prevalence of delirium is 10 to 31% in medical inpatients3, but in PD delirium 
prevalence varies from 11 to 60% across inpatient studies4. This variability is in part due to 
different operationalised criteria used to identify delirium, although in some studies 
delirium was poorly defined or not at all. Additionally, delirium in PD may be associated with 
increased hospital stay compared to those without delirium6, worsening motor symptoms 
cognitive decline and mortality.7 There are currently no studies reporting prevention or 
management of delirium in PD.4 
Well-designed studies with clearly operationalised delirium criteria are needed to accurately 
define delirium in PD and to better understand who may be at risk of developing delirium. 
This pilot study aimed to determine the prevalence and incidence of delirium in people with 
PD admitted to hospital and delirium assessment and reporting practices in clinical settings 
to informed future studies. Secondary aims were to explore differences between 
participants who did and did not have delirium. 
Methods 
Participants 
Between 26th March and 25th July 2018, all inpatients with PD admitted at Newcastle upon 
Tyne Hospitals were invited to take part in the study. Inclusion criteria comprised a 
diagnosis of PD according to UK Brain Bank Criteria5 made by a movement disorder 
specialist, and a hospital admission during the recruitment period. Exclusion criteria 
comprised a diagnosis of non-idiopathic PD; the patient was near death; the patient lacked 
capacity to give informed consent and no appropriate consultee was available; or the 
patient had insufficient English to complete the assessments.  










Written informed consent was sought from those with capacity; for patients who lacked, a 
personal consultee was identified who completed a consultee declaration form. This study 
was approved by the Yorkshire & the Humber - Bradford and Leeds Research Ethics 
Committee. 
Measures 
Participants were assessed in a single research assessment while in hospital. Demographic 
and clinical information were collected. PD motor severity was assessed using the 
Movement Disorders Society Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) Part III 
and Hoehn and Yahr stage. Frailty was measured using the Clinical Frailty Scale (CFS).8 
Prevalence of delirium was assessed prospectively using a standardised procedure using 
DSM-5 (Diagnostic and Statistical Manual of Mental Disorders 5th Edition) criteria1 based on 
the DECIDE study protocol.2 Prevalence was defined as the number of cases of delirium 
identified at the single research visit after participants were admitted to hospital during the 
four-month recruitment period.  A collateral history was taken from participants’ relative or 
carer to determine whether symptoms were an acute change or due to PD or cognitive 
impairment associated with PD. Delirium severity was assessed using the Memorial Delirium 
Assessment Scale (MDAS).9 Arousal was measured using the Observational Scale of Level of 
Arousal (OSLA),10 agitation and sedation were measured using the modified Richmond 
Agitation and Sedation Scale (m-RASS)11 and the Glasgow Coma Scale (GCS).12 Medical notes 
and patient discharge letters were reviewed for information as part of participants’ standard 
care.  
After discharge, participants’ hospital notes were reviewed over their whole admission to 
determine incident cases of delirium to capture cases that may have resolved before the 
single research visit or developed afterwards. Incidence was defined as the total number of 
cases of delirium identified during participants’ admissions to hospital during the four-
month recruitment period. Incident delirium was diagnosed using a validated consensus 
diagnosis method described by Kuhn et al.13 Detailed clinical vignettes were compiled and 
delirium symptoms were abstracted systematically. Authors (RAL, LMA, and AJY) 
independently rated each vignette as unlikely, possible, or probable delirium; 
disagreements were resolved by consensus.  











Statistical analyses were performed using SPSS software (Version 24.0; SPSS, Armonk, NY: 
IBM Corp). Comparisons of means between two groups were performed using independent 
t-tests or Mann-Whitney U tests, depending on distribution. Pearson χ2 tests were used to 
compare between-group distributions of proportion. A Wilson’s 95% confidence interval (CI) 
was calculated for all proportions. 
Results 
Over four months, 127 admissions from n=84 people with PD were screened a mean of 
28.1±20.0 hours after admission (Figure 1). Forty-four patients consented to take part in the 
study, accounting for 53 (47.1%; 95% CI 33.5-50.4%) of admissions.  
Ages of PD patients admitted to hospital ranged from 46 to 99 (mean=72.7±12.6) years. 
Patients who declined were significantly younger than study participants (67.6±15.8 vs. 
76.4±9.7 years, respectively, p<0.05). Study participants had a mean of 12.2±3.2 years of 
education and PD duration of 6.2±4.4 years (Supplementary Table 1).  
Of the 53 admissions, 90.6% (95% CI 79.8-95.9%; n=48) were emergency admissions 
(Supplementary Table 2). Mean duration of hospital stay was 11.0±12.7 days. Thirteen 
(24.5%; 95% CI 0.149-37.6%) participants were screened for delirium by the admitting team; 
of these three participants were identified as probable (n=2) or possible (n=1) delirium.  
Delirium prevalence 
The  prevalence of delirium was 34.0% (95% CI 22.7-47.4%; n=18) at the single research 
assessment (Table 1). Mean time to assessment from admission was 39.7±30.7 hours. 
Prevalent delirium PD cases had a significantly higher Hoehn and Yahr stage, frailty score, 
delirium severity measured by the MDAS and arousal score (OSLA), but lower GCS and 
agitation and sedation scores (m-RASS, p<0.05 for all, Table 1) compared to those without 
delirium at the single research assessment. No other significant differences were found 
(p>0.05 for all).  
Incident delirium 
Reviewing participants’ medical notes over the duration of their hospital stay13 identified 30 
(56.6%, 95% CI 42.3-69.1%) incident delirium cases comprising ten cases of possible and 20 










probable delirium, respectively. Only eight cases of delirium were documented (15.1%; 95% 
CI 7.2-28.1%) in participants’ medical notes, while only five cases of delirium were 
documented in discharge letters.  
Cases with incident delirium (Table 1) were significantly older and frailer (p<0.05 for both) 
compared to those who did not develop delirium during their hospital admission. Hospital 
duration was significantly longer in cases with incident delirium (mean of 14.7±15.1 vs. 
6.2±6.0 days, respectively, p<0.01). Cases with incident delirium also had significantly higher 
delirium severity measured by the MDAS and arousal score (OSLA), but lower GCS and 
agitation and sedation scores (m-RASS, p<0.05 for all, Table 1) compared to those who did 
not develop delirium. No other significant differences were found in terms of demographic 
or clinical characteristic (p>0.05 for all). 
Discussion 
To our knowledge, this is the first prospective study to investigate prevalent and incident 
delirium in hospitalised patients with PD using standardised operationalised criteria.  We 
found that prevalent delirium occurred in over a third of admissions, with incident delirium 
rising to more than half. However, delirium reporting was low both in the medical notes and 
in discharge letters. 
Our results showed that delirium was common in inpatients with PD and higher than 
previously reported in older adults (23%)14 and medical inpatients.3 Previous studies have 
suggested that PD may be a risk factor for developing delirium. However, the reported 
prevalence of delirium in PD varies widely across studies, between 11-60% in inpatients.4 
This may be due to the range of operationalised criteria previously used to identify delirium 
across studies. However, few studies explicitly addressed how each criteria were assessed. 
Although we found that delirium was common in PD, delirium reporting in medical notes 
and discharge letters was low. This is consistent with previous research.15  Since the 
completion of this study, however, hospital delirium screening guidelines have changed. 
Therefore, we would anticipate delirium reporting to be higher if this study was repeated. 
Parkinson’s patients with delirium were significantly older, frailer and had a longer stay in 
hospital compared to those without delirium. Increased age has been shown to be a risk 
factor for delirium in previous studies in PD.6  However, the link between frailty and delirium 










is not understood. There may be a dynamic relationship between the two, where frailty may 
be a risk factor for delirium, but delirium may be associated with cognitive decline and 
impeded physical recovery.16 Longer duration in hospital for cases with delirium in this study 
is consistent with studies both in older adults3 and in PD.6 This has an implication for 
increased healthcare costs.   
Strengths of this pilot study include the prospective identification of point prevalent 
delirium and incident delirium using standardised procedures.2,13 The inclusion of a 
collateral history was used to distinguish between participants’ baseline and acute changes 
associated with delirium. Limitations include the small sample size at a single site, which 
limits the generalisability of results. The assessment used a single research visit, where 
delirium present at admission may have resolved before the research assessment or 
developed afterwards. However, we used a validated consensus diagnosis method13 to 
account for episodes of delirium missed from this single review. We did not include a non-
PD control group, which limits the interpretation of results. As the participants with delirium 
were frailer, it is not possible to tell whether frailty contributed towards the development of 
delirium independent of PD. However, there were no significant differences between those 
with and without delirium in terms of number of comorbidities or medications prescribed. 
Excluding those with delirium on admission using clinical vignettes, participants who later 
developed delirium had significantly higher frailty scores compared to those who did not 
develop delirium (data not shown). Future studies should consider using an age matched 
control group. Finally, the operationalised delirium criteria and assessments to aid delirium 
have not been validated in PD. Further work is needed to understand the sensitivity and 
accuracy of these assessments in PD. 
Conclusion 
In summary, delirium is common in inpatients with PD, although delirium screening and 
documentation in medical notes were both sub-optimal. Our findings highlight the 
importance of delirium screening in inpatients with PD, both at admission and throughout 
hospital stay, but larger studies are needed with frequent evaluation to identify emergent 
delirium. Future studies should evaluate existing assessments and operationalised criteria 
for delirium for use in PD. A better understanding of delirium in PD, its presentation and 










accurate diagnostic criteria would have utility in future clinical trials to prevent or manage 
delirium.  
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 Table 1: Comparison of characteristics of prevalent cases and incident cases of delirium in 
inpatients with Parkinson’s disease 















  Mean SD Mean SD       Mean SD Mean SD     
Age 74.4 11 79.2 6.1 t= -2.1 0.044 
 
72.6 11.7 78.6 7.3 t= -2.2 0.037 
Education (years) 12.3 3.3 12.1 2.7 Z= -0.1 0.929 
 
12.6 3.6 12 2.6 Z= -0.7 0.497 
MDS-UPDRS III 49.7 14.7 56.4 17.7 t= -1.4 0.158 
 
48 15.1 55.3 15.3 t= -1.6 0.118 
Hoehn and Yahr 
stage 
3.5 1 4.3 0.8 Z= -2.5 0.012 
 
3.4 1 4 1 Z= -2.2 0.025 
PD Duration (years) 6.3 4.5 6.8 4.9 Z= -0.5 0.612 
 
6.4 5.1 6.5 4.3 Z= -0.4 0.693 
No. comorbidities 5.1 2.2 6.1 1.6 Z= -1.6 0.104 
 
5.1 2.5 5.6 1.7 Z= -0.7 0.484 
No. medications 10.2 3.7 10.9 3.2 Z= -0.7 0.46 
 
9.8 3.8 10.9 3.2 Z= -1.4 0.161 
LEDD (mg/day) 690.3 530.1 590.4 432.5 Z= -0.5 0.598 
 
617.9 492.5 685.9 507.1 Z= -0.4 0.726 
Hospital stay 
duration        
6.2 6 14.7 15.1 Z= -2.9 0.004 
Clinical Frailty Scale 5.1 1.4 6.8 0.5 Z= -4.5 <0.001 
 
4.9 1.4 6.3 1.1 Z= -3.7 <0.001 
GCS Total 14.5 1.3 12.1 1.9 Z= -4.9 <0.001 
 
14.5 1.2 13 2.1 Z= -3.2 0.002 
OSLA Total 2.5 2.4 6.1 3.3 Z= -3.8 <0.001 
 
2.3 2.6 4.8 3.3 Z= -3.0 0.003 
m-RASS 0.2 0.9 -1.1 2 Z= -2.2 0.03 
 
0.3 0.8 -0.6 1.8 Z= -1.2 0.235 
MDAS Total 8.7 3.6 17.7 5.8 t= -6.0 <0.001 
 
8 3.6 14.7 6.2 t= -5.0 <0.001 
                           
              
              
              
              
              
              
              
  n % n % χ2 
p-




Sex: male 23 65.7 12 66.7 0 0.945 
 
16 69.6 19 63.3 0.2 0.635 
Impaired on MoCA 9 25.7 1 5.6 6.4* 0.011 
 
6 26.1 4 13.3 0.4 0.527 
PD-MCI 5 14.3 6 33.3 0.9 0.763 
 
4 17.3 7 23.3 0.8 0.366 
PDD 2 5.7 4 22.2 0.7* 0.414 
 
1 4.3 5 16.7 2.7 0.102 
Emergency 
admission 
       
19 82.6 29 96.7 3.0* 0.154 
Delirium screened at 
admission 
       
5 21.7 8 26.7 0.2 0.679 
Falls as inpatient 
       
1 4.3 4 13.3 1.2* 0.374 
Increased package 
of care post 
admission 
              2 8.7 6 20 1.4* 0.234 
Significant results are highlighted in bold. * Fisher's exact test 
SD = Standard deviation; PD = Parkinson’s disease; MDS-UPDRS III = Movement Disorders Society Unified Parkinson’s 
Disease Rating Scale Part III; LEDD = Levodopa equivalent daily dose; No. = Number, GCS = Glasgow Coma Scale; OSLA = 
Observational Scale of Level of Arousal; m-RASS = modified Richmond Agitation and Sedation Scale; MDAS = Memorial 
Delirium Assessment Scale; MoCA = Montreal Cognitive Assessment; PD-MCI = Mild Cognitive Impairment in Parkinson’s 
disease; PDD = Parkinson’s disease dementia. 
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Figure 1: Flow diagram of recruitment 
iPD = idiopathic Parkinson’s disease 
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